Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients

Pharmacogenomics and Personalized Medicine ◽

10.2147/pgpm.s245086 ◽

2020 ◽

Vol Volume 13 ◽

pp. 181-188

Author(s):

Xiang Wu ◽

Qing-Jiang Xu ◽

Ping-Zhou Chen ◽

Chen-Bo Yu ◽

Lie-Fu Ye ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Prednisone Treatment ◽

Castration Resistant

Download Full-text

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment

Molecular Oncology ◽

10.1002/1878-0261.12933 ◽

2021 ◽

Author(s):

E. Boerrigter ◽

G.E. Benoist ◽

I.M. van Oort ◽

G.W. Verhaegh ◽

O. van Hooij ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Marker ◽

Liquid Biopsy ◽

Progression Free Survival ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

First Line ◽

Free Survival ◽

Prednisone Treatment ◽

Castration Resistant

Download Full-text

713 ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITHOUT PRIOR CHEMOTHERAPY - INTERIM ANALYSIS OF THE COU-AA-302 PHASE 3 TRIAL

The Journal of Urology ◽

10.1016/j.juro.2013.02.272 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Fred Saad ◽

Neal D Shore ◽

Hendrik Van Poppel ◽

Dana Rathkopf ◽

Matthew R. Smith ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Interim Analysis ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Phase 3 ◽

Prior Chemotherapy ◽

Castration Resistant

Download Full-text

Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

European Urology Oncology ◽

10.1016/j.euo.2019.01.008 ◽

2020 ◽

Vol 3 (1) ◽

pp. 119-127 ◽

Cited By ~ 2

Author(s):

Eleni Efstathiou ◽

Mark Titus ◽

Sijin Wen ◽

Patricia Troncoso ◽

Anh Hoang ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

Value in Health ◽

10.1016/j.jval.2013.08.1908 ◽

2013 ◽

Vol 16 (7) ◽

pp. A665 ◽

Cited By ~ 1

Author(s):

V. Vitale ◽

E. Asano ◽

M.L. Pereira

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Cancer Patients ◽

Impact Analysis ◽

Budget Impact ◽

Abiraterone Acetate ◽

Private Health Care ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Previously Treated

Download Full-text

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

Frontiers in Pharmacology ◽

10.3389/fphar.2017.00836 ◽

2017 ◽

Vol 8 ◽

Author(s):

Jian-Ri Li ◽

Kun-Yuan Chiu ◽

Shian-Shiang Wang ◽

Cheng-Kuang Yang ◽

Chuan-Shu Chen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Combined Androgen Blockade ◽

Castration Resistant ◽

Androgen Blockade

Download Full-text

Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-1549 ◽

2015 ◽

Vol 21 (14) ◽

pp. 3170-3177 ◽

Cited By ~ 36

Author(s):

Xu S. Xu ◽

Charles J. Ryan ◽

Kim Stuyckens ◽

Matthew R. Smith ◽

Fred Saad ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

European Urology Supplements ◽

10.1016/s1569-9056(16)60774-1 ◽

2016 ◽

Vol 15 (3) ◽

pp. e772-e772a

Author(s):

C. Van Praet ◽

S. Rottey ◽

F. Van Hende ◽

G. Pelgrims ◽

W. Demey ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Future Oncology ◽

10.2217/fon-2018-0635 ◽

2019 ◽

Vol 15 (13) ◽

pp. 1469-1479 ◽

Cited By ~ 5

Author(s):

Cem Onal ◽

Ali Murat Sedef ◽

Fatih Kose ◽

Ezgi Oymak ◽

Ozan Cem Guler ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order!

Asian Journal of Andrology ◽

10.4103/aja202155 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0

Author(s):

Charles Van Praet ◽

Valérie Fonteyne ◽

Nicolaas Lumen

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text